CEREZYME

Google image searchProduct monograph

Active ingredient

imiglucerase, 400 UNIT/VIAL

DIN: 02241751

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE DOSE VIAL

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 28-MAY-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB02 — IMIGLUCERASE (ATC/DDD)

Reference brand drug: Cerezyme

Pharmaceutical standard: MFR

External Links for Cerezyme

Search on Google

• Cerezyme side effects
• Cerezyme dosage
• imiglucerase side effects
• imiglucerase dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find cerezyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.